Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone Kristin Minkowski Carthage College Chemistry 400: Senior Seminar Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 Abstract As of late, the abuse of previously unknown steroids by professional and amateur athletes has become a major concern for athletic governing bodies. In order to detect designer steroids, which have been synthesized specifically to evade current analytical techniques, new analytical screening methods must be devised. For liquid chromatography‐tandem mass spectrometry at high collision energy, a precursor ion scan method was proposed, which allows for the detection of potential steroid analytes. The simultaneous presence of three specific fragmentation ions at m/z 105, 91, and 77 on an MS spectrum indicates a possible steroid molecule is present in the sample matrix. In addition to detection, a more efficient commercial‐grade synthesis was investigated regarding the anabolic steroid, oxandrolone. The Searle procedure was used as a starting point, for which new reagents were proposed to generate specific reaction intermediates: α‐bromoketone, enone, and hydroperoxide. Perbromides were used in place of molecular bromine to brominate the A ring, and an ozonolysis process was used in place of toxic reagents to oxidize the enone. Together, these mechanistic steps significantly increased the initial yield from 8% to 45%. At present, there is a constant battle between those synthesizing designer steroids to evade detection and those developing analytic techniques able to identify previously unknown steroids. Introduction In recent years, designer steroid abuse has been at the forefront of numerous athletic scandals, from Major League Baseball to Olympic track and field. In 2004, the UCLA Olympic Analytical Laboratory identified the compound 17α-methyl-5α-androst-2-en-17β-ol, more commonly known as the anabolic steroid madol, after receiving an oily substance not currently Page 1 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 tested for in urine analysis.1 Madol was only the third performance-enhancer, never commercially developed, to be identified as a designer steroid. While the methods for determining known steroid analytes by target detection are fairly straightforward, analytical methods for detecting new unknown designer steroids (madol) are much more problematic.2 Traditional steroid detection methods involve coupling mass spectroscopy with either gas chromatography (GC) or liquid chromatography (LC). These techniques allow the sample to be separated into its individual components before being introduced to the ionization source, important when dealing with complicated sample matrices. While GC-MS has been the industry standard since the 1980s, it has its limitations, including complicated sample pretreatment.3 Since steroids and their metabolites can be excreted as both a conjugated (sulfate or glucuronide derivatives) and unconjugated (free) fraction, sample matrices often require hydrolysis of the conjugated analytes and a derivatisation step before GC-MS analysis can be run at a suitable level of sensitivity.3 In an effort to simplify sample pretreatment, analyst’s are turning toward LC-MS/MS as the chosen instrumentation for detection of steroid compounds. Figure 1: General Steroid Structure Steroid molecules share a common four-ringed structure, composed of three cyclohexane rings (A, B, and C) and one cyclopentane ring (D). The general steroid structure and standard numbering nomenclatural is shown in figure 1. Due to additional functional groups and double Page 2 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 bonds, which can be added to this basic structure, the number of potential designer steroids is almost endless. In order to stay ahead of athlete’s abusing performance-enhancing steroids, new analytical techniques must be developed that not only detect all of the known steroids and their metabolites, but also detect all of the potential steroid analytes present in urine samples. Figure 2: Mass spectroscopy components adapted from Harris4 Pozo et al.2 utilized many distinct LC-MS/MS scan modes in an effort to design a method of steroid detection capable of identify unknown steroids. Figure 2 illustrates the specific analytical components that make up LC-MS/MS.4 To begin, a sample is separated into a series of individual components via liquid chromatography. These isolated components are then introduced to an ion source, electrospray ionization, where the eluent is sprayed through an electrically charged capillary tube. The charged solvent is sprayed from the tube and allowed to interact with nitrogen gas. The solvent eventually evaporates, leaving only the positively charged sample ions. These positively charged ions are attracted to a negative voltage potential allowing them to travel toward the mass separator.4 In tandem mass spectrometry, two quadrupoles, separated by a collision cell, are used to isolate and observe specifically selected ions based on their mass-to-charge ratios (m/z)4. In steroids, a single protonated molecule is generated via ESI- LC-MS/MS, meaning the m/z is equivalent to the mass of the protonated molecule [M + H]+. Page 3 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 Figure 3: Tandem Mass Spec Scan Techniques (a) Product ion scan, and (b) Precursor ion scan adapted from Haris.4 Pozo et al.2 used a product ion scan to establish fragmentation patterns for a diverse group of model steroid compounds (figure 3a). In this procedure, the initial quadrupole is set to select for a parent or precursor ion from a specific analyte of interest, typically the molecular ion [M + H]+. Once the [M + H]+ ion is isolated, it passes through the collision cell, where it collides with nitrogen gas, causing the ion to fragment. These fragmented ions are then analyzed and separated according to their mass-to-charge ratio by the second quadrupole. The resulting spectrum is unique for each steroid analyte under investigate. Page 4 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 The goal of Pozo et al.2 was to determine specific fragmentation ions common to known steroid molecules using LC-MS/MS, in order to more accurately predict the presence of unknown steroid molecules. Figure 3b depicts the proposed precursor ion scan used to detect the presence of a specific product ion after fragmentation. In this technique, quadrupole 1 allows all of the sample ions to be transmitted to the collision cell, and quadrupole 2 is selected to monitor only one specific fragment ion. By analyzing the various fragmentation pathways of a wide- variety of steroid compounds at high collision energy, Pozo et al. were able to isolate three common fragmentation ions. Their proposed technique provides researchers with a straightforward method to determine previously unidentified steroid compounds in a sample matrix. Figure 4: Structures of methylandrostanolone and oxandrolone As new analytical techniques are being created to aid in steroid detection, new synthetic pathways are also being devised in an effort to create either new undetectable compounds, i.e. designer steroids, or to improve overall synthetic yield in commercially produced steroid compounds.5 In order to produce commercial quantities of the anabolic steroid oxandrolone (figure 4), Cabej et al. used the initial Counsell and Pappo synthesis6 as a starting point (scheme 1). Page 5 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 Scheme 1: Counsell / Pappo sythesis of Oxandrolone (a) Br , NaOAc, HOAc, RT (b) LiCl, Li CO , DMF, (c) 2 2 3 OsO , Pb(OAc) , HOAc, H O, RT (d) NaBH , NaOH, RT adapted from Cabej et al.5 & Counsell et al.6 4 4 2 4 Cabej et al. focused on three specific areas upon which the original synthesis needed to be improved. First, they needed to address the low overall percent yield for oxandrolone, which was only 8% for the Counsell / Pappo synthesis.6 Second, they needed to find alternatives for toxic reagents used in the initial synthesis, such as molecular bromine.7 Finally, they needed to elimination purification via column chromatography8, which is not feasible for a commercial synthesis. After numerous mechanistic modifications, Cabej et al.5 were able to increase the overall yield of oxandrolone to 45% and make commercial production a more viable option. Results The purpose of Cabej et al.5 was to modify the original synthesis of the anabolic steroid oxandrolone, in order to make it more suitable for commercial-scale production. The initial Searle synthesis, developed by Counsell and Pappo6 (scheme 1), was used as the starting point for the newly proposed up scaling of the oxandrolone synthesis; however, alterations were made Page 6 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 at numerous steps of the synthetic pathway. Adjustments were necessary in the oxidation step, due to the toxicity of osmium tetroxide and lead acetate reagents. In addition, the initial synthesis required purification via column chromatography of the bromoketone and enone intermediates, which is not feasible for large-scale production. Finally, Cabej et al. addressed the relative low yields for specific reaction intermediates. While the Searle synthesis was an excellent guide, the newly proposed synthesis of oxandrolone from methylandrostanolone was more direct and efficient. Beginning with methylandrostanolone, Counsell and Pappo brominated C(2) using bromine in a sodium acetate/acetic acid solution to produce the bromoketone intermediate. Due to competing reactions, this bromination process only gave the bromoketone intermediate in a 43% yield. Hydrobromic acid (HBr) was a byproduct of the bromination, and its acidic properties led to competing dehydration reactions on the C(17) alcohol group, lowering the overall bromoketone intermediate yield. Cabej et al. addressed this issue by brominating methylandrostanolone with perbromides, first phenyltrimethyl ammonium bromide (PTAB) and then due to its cost efficiency, pyridinium tribromide (PyHBr ). While PTAB in the aprotic 3 solvent tetrahydrofuran (THF) gave an 85% yield during the initial small-scale procedure, similar results were not observed once performed on the commercial level. THF, a cyclic ether (figure 6), interacts with HBr yielding 4-bromo-1-butanol, a compound capable of remaining in the product after bromination of C(2) takes place. During the drying process, 4-bromo-1- butanol transforms back into THF, releasing HBr, which dehydrates the C(17) alcohol. Since the THF solvent was responsible for the acid trapping and subsequent dehydration, Cabej et al. removed THF as a solvent and performed the PTAB bromination in a variety of solvents. Table 1 highlights the reaction conditions, percent yields, and percent purities for each solvent. Percent Page 7 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 yield reflects the amount of product obtained verse the expected or calculated amount of product; whereas, the percent purity only takes into account the bromoketone present in the product collected (bromoketone + impurities) determined via HPLC analysis. Table 1: Bromination of methylandrostanolone with PTAB in different solvents entry conditions percent yield (%) percent purity (%) comments 1 THF/0°C EtAOc extraction 75 92-94 HBr trap/dehydration 2 DME/0°C 64 not determined bromoketone insoluble 3 EtOAc/0°C 73 97 bromoketone insoluble 4 CH Cl /0°C not determined not determined dehydration 2 2 5 EtOH/RT 88 90 ketal formed 6 EtOH/8% H O/RT 84 89 rx time 5.5 h 2 7 EtOH/14% H O/RT 82 91 rx time 24 h (slow) 2 8 MeOH/RT not determined not determined ketal formed Figure 6: Bromination solvent structures (a) Tetrahydrofuran (THF), (b) Dimethoxyethane (DME), (c) Ethyl Acetate (EtOAc) The bromination was performed in both protic (EtOH, H 0, MeOH) and aprotic (THF, 2 DME, EtOAc, CH Cl) solvents. Figure 6 illustrates the structure of three of the polar aprotic 2 solvents used in the bromination: THF, DME, and EtOAc. As mentioned above, THF as a solvent on the commercial level led to HBr trapping and resulted in late-stage dehydration, despite the small-scale success evident by percent yield and percent purity in Table 1. Entry 2 using DME and Entry 3 using EtOAc not only had low percent yields, 64% and 73%, but also made isolating the bromoketone intermediate difficult due to its insolubility in both solvents. Entry 4 was performed in dichloromethane; however, due to dehydration of the C(17) alcohol, the percent yield and corresponding bromoketone purity were deemed to low to analyze. Entry 5 and 8 were run in ethanol and methanol only (in the absence of water) and resulted in the formation of a ketal at C(3). The presence of the ketal was not observed in entries 6 and 7, and it is hypothesized that the addition of water to the ethanol solvent medium (at eight and fourteen Page 8 of 28 Detection of Designer Anabolic Steroids by LC‐MS/MS and Commercial Synthesis of Oxandrolone 11/18/10 percent respectively) hydrolyzes the ketal back to into a ketone. In the presence of too much water (entry 7), the reaction proceeds at a much slower rate (24 hours vs. 5.5 hours), and with similar percent yields and percent purities, the commercial scale process would be most efficient in the ethanol / 8% water solvent. Scheme 2: Reaction intermediates (A ring) during commercial synthesis of oxandrolone (a) PyHBR , ETOH, 3 H 0, Na S O 5H 0 (aq), Na CO (aq) (b) LiBr, Li CO , DMF, Acetic Acid, H 0, EtOAC, Heptane (c) O , 2 2 2 3 2 2 3 2 3 2 3 MeOH, NaOH, HCl, MeOH/H O (d) NaOH, EtOH, H O, NaBH , HCl, Filter, MeOH, H O 2 2 4 2 Due to its lower cost and its solubility in ethanol, PyHBr was used as the brominating 3 agent in place of PTAB. Sodium thiosulfate pentahydrate and sodium carbonate were added stepwise to the slurry to quench or neutralize the perbromide and adjust the pH. Scheme 2 illustrates the newly proposed commercial-grade synthesis of Oxandrolone, focusing on the A ring of the steroid. Reacting PyHBr with methylandrostanolone in an ethanol/8% water solvent 3 produces the bromoketone intermediate in the first step of the synthesis at an 82% yield (92% purity). Scheme 3 illustrates the reaction mechanism resulting in the α-bromoketone intermediate. The key to this reaction proceeding is the formation of the enol isomer from the original ketone functional group. In the presence of an acid (PyH+), the carboxyl group is protonated, followed by the removal of an α hydrogen at C(2), the formation of a C(2)-C(3) double bond, and the creation of a C(3) alcohol. The presence of the alkene (en) and alcohol (ol) give rise to the name of the isomer (enol). Following the electron arrows, the enol acts as a nucleophile and attacks Page 9 of 28
Description: